Oral and Topical Terbinafine for Fungal Infections in Pregnancy. 2020

Mary Kathryn Abel, and Jenny E Murase
Department of Dermatology, University of California, San Francisco.

UI MeSH Term Description Entries
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000022 Abortion, Spontaneous Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference. Abortion, Tubal,Early Pregnancy Loss,Miscarriage,Spontaneous Abortion,Abortions, Spontaneous,Abortions, Tubal,Early Pregnancy Losses,Loss, Early Pregnancy,Losses, Early Pregnancy,Miscarriages,Pregnancy Loss, Early,Pregnancy Losses, Early,Spontaneous Abortions,Tubal Abortion,Tubal Abortions
D000077291 Terbinafine A naphthalene derivative that inhibits fungal SQUALENE EPOXIDASE and is used to treat DERMATOMYCOSES of the skin and nails. (E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride,DA 5505,Lamisil,SF 86-327,SF-86-327,TDT-067,Terbinafine Hydrochloride,Terbinafine, (Z)-,Terbinafine, (Z)-isomer,SF 86 327,SF 86327,SF86327,TDT 067,TDT067
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

Mary Kathryn Abel, and Jenny E Murase
December 2020, Drug and therapeutics bulletin,
Mary Kathryn Abel, and Jenny E Murase
August 1993, The Medical letter on drugs and therapeutics,
Mary Kathryn Abel, and Jenny E Murase
May 1994, The Nurse practitioner,
Mary Kathryn Abel, and Jenny E Murase
January 2005, The Journal of dermatological treatment,
Mary Kathryn Abel, and Jenny E Murase
January 1991, Clinics in dermatology,
Mary Kathryn Abel, and Jenny E Murase
January 1997, Dermatology (Basel, Switzerland),
Mary Kathryn Abel, and Jenny E Murase
January 2004, American journal of clinical dermatology,
Mary Kathryn Abel, and Jenny E Murase
April 2017, Materials science & engineering. C, Materials for biological applications,
Mary Kathryn Abel, and Jenny E Murase
February 1992, Postgraduate medicine,
Mary Kathryn Abel, and Jenny E Murase
August 2009, Chinese medical journal,
Copied contents to your clipboard!